Tufts engineers bacteria to produce rare healthy sugar

Scientists at Tufts University have developed a method using genetically modified bacteria to efficiently produce tagatose, a rare sugar that mimics table sugar's taste with fewer health risks. This breakthrough could provide a low-calorie alternative that supports oral and gut health without spiking blood sugar. The innovation achieves yields up to 95 percent, far surpassing traditional production techniques.

For over a century, researchers have sought sugar substitutes that deliver sweetness without the calories, tooth decay, and risks of obesity and diabetes linked to sucrose. A new study from Tufts University brings a promising solution: biosynthetic production of tagatose, a naturally rare sugar found in tiny amounts in dairy and fruits like apples and pineapples.

Tagatose offers 92 percent of sucrose's sweetness but with about 60 percent fewer calories. Classified by the FDA as "generally recognized as safe," it is absorbed minimally in the small intestine and fermented by gut bacteria, resulting in little impact on blood glucose or insulin levels. Studies show it limits cavity-causing oral bacteria and may promote beneficial microbes in the mouth and gut.

The Tufts team, led by Nik Nair, associate professor of chemical and biological engineering, engineered Escherichia coli bacteria as "tiny factories." They incorporated a slime mold enzyme, galactose-1-phosphate-selective phosphatase (Gal1P), to convert abundant glucose into galactose, followed by arabinose isomerase to yield tagatose. "There are established processes to produce tagatose, but they are inefficient and expensive," Nair said. This method boosts yields to 95 percent, compared to 40-77 percent in prior techniques, making it more economical.

Unlike high-intensity sweeteners, tagatose acts as a bulk sweetener, browning like sugar when heated and matching its mouthfeel. "The key innovation... was in finding the slime mold Gal1P enzyme and splicing it into our production bacteria," Nair explained. Published in Cell Reports Physical Science in 2025, the research could enable efficient synthesis of other rare sugars, potentially transforming food production for healthier options.

관련 기사

Illustration of Australian scientists developing antibodies targeting bacteria-specific sugar to treat drug-resistant infections in mice.
AI에 의해 생성된 이미지

Australian team develops antibodies targeting a bacteria-only sugar, clearing drug-resistant infection in mice

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Australian researchers report they have engineered monoclonal antibodies that recognize pseudaminic acid—a sugar made by bacteria but not by humans—and used them to help eliminate multidrug-resistant Acinetobacter baumannii infections in mice, a step toward potential passive-immunotherapy treatments for hard-to-treat hospital infections.

Researchers at the University of Waterloo have developed engineered bacteria designed to invade and eat solid tumors from the inside out. The approach uses microbes that thrive in oxygen-free environments, targeting the low-oxygen cores of tumors. A genetic modification allows the bacteria to survive near oxygenated edges, controlled by a quorum-sensing mechanism.

AI에 의해 보고됨 사실 확인됨

Researchers at the Massachusetts Institute of Technology report that intelectin-2, a carbohydrate-binding lectin found in the gastrointestinal tract, can both crosslink mucus components to reinforce the gut’s protective barrier and bind certain bacteria, restricting their growth and reducing viability—findings that may inform future approaches to drug-resistant infections and inflammatory bowel disease.

Researchers at the University of Colorado Boulder have found that erythritol, a common sugar substitute, disrupts brain blood vessel cells in ways that could elevate stroke risk. The study exposed cells to levels from a single sugar-free drink and observed reduced vessel relaxation, impaired clot breakdown, and increased oxidative stress. The findings appear in the Journal of Applied Physiology.

AI에 의해 보고됨 사실 확인됨

Researchers have developed tiny ingestible hydrogel microspheres packed with engineered bacteria that glow when they encounter blood in the gut, potentially offering a quick, noninvasive way to monitor intestinal disease. In mouse models of colitis, the sensors detected heme — a component of blood — within minutes and produced stronger signals as disease severity increased.

A retired US Marine officer in Massachusetts, plagued by a gut that brewed its own alcohol, has seen his symptoms resolve after receiving faecal transplants from a healthy donor. The treatment targeted the rare auto-brewery syndrome, where gut microbes ferment sugars into intoxicating levels of alcohol. This case highlights potential new avenues for managing the condition triggered by antibiotic use.

AI에 의해 보고됨

Researchers have developed a method to transform carrot processing leftovers into a nutritious protein source using edible fungi, which volunteers preferred in vegan foods over traditional options. This innovation addresses global food security by repurposing waste into sustainable alternatives. The study highlights the potential of fungal mycelium to reduce environmental impact while providing high-quality nutrition.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부